Overview

A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Assessing the safety and tolerability of Oxycodone Hydrochloride 50mg/mL in subjects with severe cancer pain.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma Research Limited
Treatments:
Oxycodone